1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Comparison of predictive accuracy defined as AUC on ROC analyses reported in the 2 studies^1,4
Molecular Subgrouping of Medulloblastoma AUC Using Radiomic MRI Signatures AUC Using Semantic MRI Features
Double 10-Fold Cross-Validation Model 3-Dataset Cross-Validation Model Training Cohort (n = 76) Validation Cohort (n = 35)
WNT 0.45 0.45 0.75 0.69
SHH 0.79 0.70 0.94 0.99
Group 3 0.70 0.39 0.73 0.60
Group 4 0.83 0.80 0.85 0.79

Molecular Subgrouping of Medulloblastoma	AUC Using Radiomic MRI Signatures		AUC Using Semantic MRI Features
Molecular Subgrouping of Medulloblastoma	Double 10-Fold Cross-Validation Model	3-Dataset Cross-Validation Model	Training Cohort (n = 76)	Validation Cohort (n = 35)
WNT	0.45	0.45	0.75	0.69
SHH	0.79	0.70	0.94	0.99
Group 3	0.70	0.39	0.73	0.60
Group 4	0.83	0.80	0.85	0.79